Stock Events

Stock Events

Apellis Pharmaceuticals (1JK.F) Q3 2024 Earnings

1AugConfirmed

Q4 2023

Q2 2024

Q3 2024

-0.67

-0.54

-0.41

-0.28

Details

Expected EPS

-0.28379401875

Actual EPS

-0.27802499999999997

Surprise EPS

0.01

Surprise Percent

+2.03%

Description

Apellis Pharmaceuticals (1JK.F) has reported earnings of -0.27802499999999997 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.